Patents by Inventor Sebastiano Banni
Sebastiano Banni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230047556Abstract: Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cytokines.Type: ApplicationFiled: July 27, 2022Publication date: February 16, 2023Inventors: Inge Bruheim, Mikko Griinari, Sebastiano Banni, Per Christian Saebo, Erik Fuglseth
-
Patent number: 11400105Abstract: Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cytokines.Type: GrantFiled: January 6, 2020Date of Patent: August 2, 2022Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Mikko Griinari, Sebastiano Banni, Per Christian Saebo, Erik Fuglseth
-
Patent number: 10525068Abstract: Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cytokines.Type: GrantFiled: November 5, 2018Date of Patent: January 7, 2020Assignee: Aker BioMarine Antarctic ASInventors: Inge Bruheim, Mikko Griinari, Sebastiano Banni, Per Christian Saebo, Erik Fuglseth
-
Patent number: 10117882Abstract: Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cytokines.Type: GrantFiled: August 4, 2010Date of Patent: November 6, 2018Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Mikko Griinari, Sebastiano Banni, Per Christian Saebo, Erik Fuglseth
-
Publication number: 20170258924Abstract: An ester of a phospholipid with conjugated linoleic acid for use in the therapeutic treatment of or as a food supplement for psychiatric disorders with neuroinflammatory and neurodegenerative basis, such as depression and schizophrenia.Type: ApplicationFiled: July 27, 2015Publication date: September 14, 2017Applicant: UNIVERSITA' DEGLI STUDI DI CAGLIARIInventors: Sebastiano Banni, Miriam Melis, Marco Pistis, Valeria Sogos
-
Patent number: 9730966Abstract: This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. Further, a method of reducing appetite in humans by administering a krill oil composition is also disclosed.Type: GrantFiled: December 14, 2015Date of Patent: August 15, 2017Assignee: AKER BIOMARINE ANTARTIC ASInventors: Inge Bruheim, Snorre Tilseth, Jeffery Cohn, Mikko Griinari, Sebastiano Banni, Daniele Mancinelli, Nils Hoem, Hogne Vik
-
Publication number: 20160166527Abstract: A composition for use in developing and/or improving brain function comprises a glyceride having a palmitoyl group at the 2-position wherein at least 40% by weight of the palmitic acid content of the composition is present as palmitoyl groups bonded at the 2-position of a glyceride.Type: ApplicationFiled: July 31, 2014Publication date: June 16, 2016Applicant: Loders Croklaan B.V.Inventors: Luisa Gambelli, Randolph Happe, Sebastiano Banni
-
Publication number: 20160095888Abstract: This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.Type: ApplicationFiled: December 14, 2015Publication date: April 7, 2016Inventors: Inge Bruheim, Snorre Tilseth, Jeffery Cohn, Mikko Griinari, Sebastiano Banni, Daniele Mancinelli, Nils Hoem, Hogne Vik
-
Patent number: 9220735Abstract: This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.Type: GrantFiled: April 3, 2014Date of Patent: December 29, 2015Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Jeffery Cohn, Mikko Griinari, Sebastiano Banni, Daniele Mancinelli, Nils Hoem, Hogne Vik
-
Patent number: 9034388Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: March 28, 2008Date of Patent: May 19, 2015Assignee: AKER BIOMARINE ANTARTIC ASInventors: Inge Bruheim, Mikko Griinari, Snorre Tilseth, Sebastiano Banni, Jeffrey Stuart Cohn, Daniele Mancinelli
-
Publication number: 20140363517Abstract: This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.Type: ApplicationFiled: April 3, 2014Publication date: December 11, 2014Applicant: AKER BIOMARINE ASInventors: Inge BRUHEIM, Snorre TILSETH, Jeffery COHN, Mikko GRIINARI, Sebastiano BANNI, Daniele MANCINELLI, Nils HOEM, Hogne VIK
-
Patent number: 8697138Abstract: This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondrial respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.Type: GrantFiled: May 28, 2010Date of Patent: April 15, 2014Assignee: Aker Biomarine ASInventors: Inge Bruheim, Snorre Tilseth, Jeffery Cohn, Mikko Griinari, Daniele Mancinelli, Nils Hoem, Hogne Vik, Sebastiano Banni
-
Publication number: 20110306664Abstract: Medical dietary composition for treating neurodegenerative diseases such as Alzheimer, Parkinson's disease, and more preferably adrenoleukodystrophy comprising a mixture of glyceryl trioleate (GTO), glyceryl trierucate (GTE) and at least one conjugated linoleic acid as active ingredient, in combination with suitable excipients and/or diluents.Type: ApplicationFiled: June 14, 2011Publication date: December 15, 2011Applicant: SOFEDUS S.R.L.Inventors: Anna PETRONI, Sebastiano BANNI, Marco CAPPA
-
Publication number: 20110104297Abstract: This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondrial respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.Type: ApplicationFiled: May 28, 2010Publication date: May 5, 2011Applicant: Aker BioMarine A.S.A.Inventors: Inge BRUHEIM, Snorre Tilseth, Jeffery Cohn, Mikko Griinari, Daniele Mancinelli, Nils Hoem, Hogne Vik, Sebastiano Banni
-
Publication number: 20100316680Abstract: Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cytokines.Type: ApplicationFiled: August 4, 2010Publication date: December 16, 2010Applicant: AKER BIOMARINE ASAInventors: Inge Bruheim, Mikko Griinari, Sebastiano Banni, Per Christian Saebo, Erik Fuglseth
-
Publication number: 20080274203Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: ApplicationFiled: March 28, 2008Publication date: November 6, 2008Applicant: AKER BIOMARINE ASAInventors: Inge Bruheim, Mikko Griinari, Snorre Tilseth, Sebastiano Banni, Jeffrey Stuart Cohn, Daniele Mancinelli
-
Publication number: 20080044487Abstract: Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cytokines.Type: ApplicationFiled: May 4, 2007Publication date: February 21, 2008Applicant: Natural ASAInventors: Inge Bruheim, Mikko Griinari, Sebastiano Banni, Per Christian Saebo, Erik Fuglseth